Current state of diabetes mellitus prevalence, awareness, treatment, and control in Latin America: challenges and innovative solutions to improve health outcomes …
ML Avilés-Santa, A Monroig-Rivera, A Soto-Soto… - Current diabetes …, 2020 - Springer
Abstract Purpose of Review Latin America is the scenario of great inequalities where about
32 million human beings live with diabetes. Through this review, we aimed at describing the …
32 million human beings live with diabetes. Through this review, we aimed at describing the …
Management of diabetes in Morocco: results of the International Diabetes Management Practices Study (IDMPS)–wave 5
A Chadli, S El Aziz, N El Ansari, F Ajdi… - Therapeutic …, 2016 - journals.sagepub.com
Objectives: The International Diabetes Mellitus Practice Study (IDMPS) is a 5-year survey
documenting changes in diabetes treatment practices in developing countries. The primary …
documenting changes in diabetes treatment practices in developing countries. The primary …
Proportion of Brazilian diabetes patients that achieve treatment goals: implications for better quality of care
DR Baptista, RD Thieme, WCT Reis… - Diabetology & Metabolic …, 2015 - Springer
Background Diabetes and its complications are substantial causes of morbidity and
mortality, and caused approximately 5.1 million deaths worldwide in 2013. Early detection …
mortality, and caused approximately 5.1 million deaths worldwide in 2013. Early detection …
Control de glucosa en pacientes que asistieron al programa de educación DiabetIMSS en Tecate, Baja California
E Romero-Valenzuela, A Zonana-Nacach… - Medicina Interna De …, 2014 - medigraphic.com
Antecedentes: la diabetes mellitus es actualmente la principal enfermedad crónica y sólo
una pequeña proporción de pacientes tiene buen control metabólico en países …
una pequeña proporción de pacientes tiene buen control metabólico en países …
Patients' empowerment, physicians' perceptions, and achievement of therapeutic goals in patients with type 1 and type 2 diabetes mellitus in Mexico
FJ Lavalle-Gonzalez, E Chiquete - Patient preference and …, 2016 - Taylor & Francis
Background Physicians' perception may not parallel objective measures of therapeutic
targets in patients with diabetes. This is an issue rarely addressed in the medical literature …
targets in patients with diabetes. This is an issue rarely addressed in the medical literature …
Comparative effectiveness of vildagliptin in combination with other oral anti-diabetes agents in usual-care conditions: the EDGE–Latin America study
CO Mendivil, E Márquez-Rodríguez… - Current Medical …, 2014 - Taylor & Francis
Objective: To assess the proportion of patients on vildagliptin add-on dual therapy who
respond to treatment over a 12 month follow-up, relative to comparator oral anti-diabetes …
respond to treatment over a 12 month follow-up, relative to comparator oral anti-diabetes …
Evaluación de la calidad en cuidados médicos prestados a pacientes diabéticos: Un ciclo de mejora
A Navarro-Martínez, MP Suárez-Beke… - Revista de Calidad …, 2014 - Elsevier
Objetivo Evaluar y mejorar la calidad de los cuidados médicos prestados a pacientes
diabéticos a través de los estándares propuestos por la Asociación Americana de Diabetes …
diabéticos a través de los estándares propuestos por la Asociación Americana de Diabetes …
Frecuencia de daño renal y síndrome metabólico en pacientes con Diabetes mellitus tipo 2 y/o Hipertensión arterial en el primer nivel de atención rural y evaluación …
JA Acosta-Leyva, R Ruiz-Ríos… - Revista Médica de la …, 2012 - medigraphic.com
En los pacientes con Diabetes mellitus tipo 2 (DM2) y con hipertensión arterial sistémica
(HAS), la morbimortalidad se incrementa con el desarrollo de enfermedad renal crónica …
(HAS), la morbimortalidad se incrementa con el desarrollo de enfermedad renal crónica …
Mexican population sub-analysis of the lixilan clinical program with the fixed ratio combination of insulin glargine and lixisenatide (iGlarLixi)
G Gonzalez-Galvez, ML Diaz-Toscano… - Journal of Diabetes and …, 2020 - Elsevier
Aim To evaluate the efficacy and safety of iGlarLixi in Mexican patients with type 2 diabetes
who participated in the LixiLan clinical trials and compare results with the rest of the patients …
who participated in the LixiLan clinical trials and compare results with the rest of the patients …
[PDF][PDF] Higher risk of uncontrolled disease and very poor glycemic control in younger patients with type 2 diabetes.
JM López-Navarro, I Pérez-Díaz… - Revista Mexicana de …, 2018 - researchgate.net
Objective: This research aims to identify the risk factors associated with poor glycemic
control in patients with Type 2 diabetes. Methods: A retrospective and transversal study was …
control in patients with Type 2 diabetes. Methods: A retrospective and transversal study was …